Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Lexicon Pharmaceuticals, Inc. (LXRX) had Weighted-Average Shares Outstanding (Basic) of 437.65M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.69M |
|
$-31.77M |
|
$0.04M |
|
$0.65M |
|
$27.23M |
|
$-26.54M |
|
$-5.24M |
|
$-31.77M |
|
$-31.77M |
|
$-31.77M |
|
$-31.77M |
|
$-31.77M |
|
$-31.77M |
|
$-26.54M |
|
$-25.91M |
|
|
Weighted-Average Shares Outstanding (Basic) |
437.65M |
437.65M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$196.58M |
|
$1.65M |
|
$53.48M |
|
$250.06M |
|
$14.71M |
|
$51.44M |
|
$60.83M |
|
$75.53M |
|
$174.53M |
|
$129.98M |
|
$174.53M |
|
444.94M |
|
| Cash Flow Statement Financials | |
$-23.92M |
|
$-86.72M |
|
$88.24M |
|
$63.33M |
|
$40.92M |
|
$-22.40M |
|
$6.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.37 |
|
-- |
|
-- |
|
0.23 |
|
0.29 |
|
94.36% |
|
-3835.26% |
|
-3835.26% |
|
-- |
|
-4591.76% |
|
-4591.76% |
|
$-23.92M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
0.42 |
|
213.69 |
|
-18.21% |
|
-24.45% |
|
-12.71% |
|
-14.06% |
|
$0.39 |
|
$-0.05 |
|
$-0.05 |
|